The SATELLITE trial (Safety and Tolerability Study of AZD4831 in Patients with Heart Failure) investigated the MPO inhibitor AZD4831 (Mitiperstat) in patients with heart failure [118]. The gene discussed is MPO; the disease is heart failure.